Healthcare provider profile · identity verified

Josephine Mee Devaraj, D.O.

Family Practice · EL MONTE, CA · NPI 1285867820

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	916	329
Amlodipine Besylate	Amlodipine Besylate	457	183
Levothyroxine Sodium	Levothyroxine Sodium	399	134
Metformin Hcl	Metformin Hcl	337	124
Losartan Potassium	Losartan Potassium	316	128
Gabapentin	Gabapentin	294	126
Metformin Hcl Er	Metformin Hcl	286	107
Lisinopril	Lisinopril	275	102
Alendronate Sodium	Alendronate Sodium	270	95
Omeprazole	Omeprazole	247	108
Fluticasone Propionate	Fluticasone Propionate	241	138
Tamsulosin Hcl	Tamsulosin Hcl	236	94
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	196	69
Ibuprofen	Ibuprofen	190	96
Meloxicam	Meloxicam	184	71
Metoprolol Succinate	Metoprolol Succinate	184	63
Vitamin D2	Ergocalciferol (Vitamin D2)	181	85
Pravastatin Sodium	Pravastatin Sodium	175	75
Pioglitazone Hcl	Pioglitazone Hcl	170	66
Benazepril Hcl	Benazepril Hcl	169	58
Hydrochlorothiazide	Hydrochlorothiazide	167	66
Rosuvastatin Calcium	Rosuvastatin Calcium	161	68
Glipizide	Glipizide	153	59
Famotidine	Famotidine	149	59
Pantoprazole Sodium	Pantoprazole Sodium	147	59
Mirtazapine	Mirtazapine	141	58
Albuterol Sulfate Hfa	Albuterol Sulfate	136	63
Furosemide	Furosemide	130	60
Glipizide Er	Glipizide	127	48
Ozempic	Semaglutide	120	25
Simvastatin	Simvastatin	114	43
Finasteride	Finasteride	111	45
Januvia	Sitagliptin Phosphate	108	43
Sertraline Hcl	Sertraline Hcl	107	42
Azelastine Hcl	Azelastine Hcl	104	43
Meclizine Hcl	Meclizine Hcl	104	42
Lovastatin	Lovastatin	97	33
Donepezil Hcl	Donepezil Hcl	96	39
Montelukast Sodium	Montelukast Sodium	92	38
Azithromycin	Azithromycin	90	78
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	29
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	86	29
Diclofenac Sodium	Diclofenac Sodium	86	35
Eliquis	Apixaban	86	28
Naproxen	Naproxen	86	26
Prednisone	Prednisone	86	76
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	32
Trazodone Hcl	Trazodone Hcl	78	30
Latanoprost	Latanoprost	75	27
Alprazolam	Alprazolam	74	33
Jardiance	Empagliflozin	73	17
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	72	29
Metoprolol Tartrate	Metoprolol Tartrate	71	28
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	70	37
Ezetimibe	Ezetimibe	70	28
Baclofen	Baclofen	69	40
Clonidine Hcl	Clonidine Hcl	69	26
Atenolol	Atenolol	68	26
Carvedilol	Carvedilol	65	28
Cephalexin	Cephalexin	60	44
Tramadol Hcl	Tramadol Hcl	60	31
Triamcinolone Acetonide	Triamcinolone Acetonide	59	38
Glipizide-Metformin	Glipizide/Metformin Hcl	56	20
Lorazepam	Lorazepam	56	15
Clopidogrel	Clopidogrel Bisulfate	55	20
Glimepiride	Glimepiride	54	19
Clonazepam	Clonazepam	53	16
Doxycycline Hyclate	Doxycycline Hyclate	49	39
Propranolol Hcl	Propranolol Hcl	48	18
Felodipine Er	Felodipine	47	17
Hydroxyzine Hcl	Hydroxyzine Hcl	46	26
Rybelsus	Semaglutide	44	19
Acetaminophen-Codeine	Acetaminophen With Codeine	43	27
Hydralazine Hcl	Hydralazine Hcl	43	20
Pregabalin	Pregabalin	41	15
Dicyclomine Hcl	Dicyclomine Hcl	40	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	40	21
Amitriptyline Hcl	Amitriptyline Hcl	38	11
Memantine Hcl	Memantine Hcl	38	12
Citalopram Hbr	Citalopram Hydrobromide	37	11
Fluoxetine Hcl	Fluoxetine Hcl	36	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	25
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	12
Allopurinol	Allopurinol	34	11
Ketoconazole	Ketoconazole	34	20
Olmesartan Medoxomil	Olmesartan Medoxomil	34	12
Ondansetron Hcl	Ondansetron Hcl	34	30
Oxybutynin Chloride	Oxybutynin Chloride	33	14
Tolterodine Tartrate Er	Tolterodine Tartrate	32	14
Advair Hfa	Fluticasone Propion/Salmeterol	31	suppressed
Lactulose	Lactulose	31	20
Nystatin	Nystatin	31	suppressed
Sildenafil Citrate	Sildenafil Citrate	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	26
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	30	suppressed
Hydrocortisone	Hydrocortisone	30	19
Nifedipine Er	Nifedipine	29	suppressed
Loperamide	Loperamide Hcl	27	13
Tradjenta	Linagliptin	27	11
Clindamycin Phosphate	Clindamycin Phosphate	26	15
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	25	13
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	25	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Estradiol (Twice Weekly)	Estradiol	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	19	suppressed
Progesterone	Progesterone, Micronized	19	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Ibu	Ibuprofen	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Valsartan	Valsartan	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Clotrimazole	Clotrimazole	15	11
Entresto	Sacubitril/Valsartan	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Haloperidol	Haloperidol	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Linzess	Linaclotide	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Ofloxacin	Ofloxacin	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error